GBA Gaucher Carrier Test
Targeted sequencing of GBA for Gaucher disease carrier status.
Methodology
NGS with Sanger confirmation
Genes analyzed
GBA
Sample type
3 mL EDTA Whole Blood
Turnaround time
7–10 Business Days
Understand the test
What this test is for
Expert oversight
Doctor's clinical note
This test page is presented for education and care coordination. The appropriate use and interpretation of a test should be discussed with a qualified healthcare professional.
Clinical context
Who is this test for?
These examples help explain when this test may be considered. They are not a diagnosis or a substitute for clinical judgment.
Interpretation guide
Understanding results
A laboratory result is interpreted alongside personal history, family history, and other clinical information. Your healthcare professional is the right person to explain what your report means.
Before your sample
No fasting required unless your kit insert says otherwise. Bring a photo ID and, when applicable, the clinician order and insurance card.
Important limitations
No genetic test detects every possible cause of a condition. A negative, positive, or uncertain result may have different implications depending on the clinical context and test scope.
Common questions
Frequently asked questions
Patients and families should discuss test selection with the healthcare professional responsible for their care. Our team can help with logistics and general test information.
Results are interpreted with personal history, family history, and other clinical information. A qualified healthcare professional should explain the report and next steps.
Further reading
References
Test-specific references will be displayed here after they are added and reviewed by the GGC DNA clinical team.
Continue exploring
Related tests
Expanded Carrier Screening (100+ genes)
Screening for 100+ autosomal and X-linked recessive conditions.
View test →Cystic Fibrosis Carrier Test
CFTR gene analysis for cystic fibrosis carrier status.
View test →CFTR Full-Gene Sequencing & Deletion Analysis
Full CFTR sequencing with intron-8 polyT and TG-repeat analysis.
View test →SMN1/SMN2 Spinal Muscular Atrophy Carrier Test
Dosage-based carrier screening for spinal muscular atrophy.
View test →This page is for educational and informational purposes only. It does not provide a diagnosis or replace advice from a qualified healthcare professional. Test selection and result interpretation should be discussed with the clinician responsible for your care.